IBEX (NASDAQ:IBEX - Get Free Report) is anticipated to release its Q1 2027 results after the market closes on Thursday, November 5th. Analysts expect IBEX to post earnings of $0.90 per share and revenue of $169.31 million for the quarter. Interested persons may visit the company's upcoming Q1 2027 earnings report for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.
IBEX (NASDAQ:IBEX - Get Free Report) last issued its quarterly earnings data on Friday, September 11th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.01. The company had revenue of $164.27 million for the quarter, compared to analyst estimates of $160.02 million. IBEX had a net margin of 7.19% and a return on equity of 28.96%.
IBEX Stock Down 0.6%
NASDAQ IBEX opened at $45.65 on Thursday. The firm has a market cap of $606.23 million, a PE ratio of 14.58 and a beta of 0.69. The company has a 50 day moving average price of $41.80 and a 200 day moving average price of $34.25. IBEX has a 52 week low of $25.94 and a 52 week high of $48.17.
Insider Transactions at IBEX
In other news, COO David Afdahl sold 17,500 shares of the stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $37.09, for a total transaction of $649,075.00. Following the transaction, the chief operating officer owned 140,006 shares in the company, valued at $5,192,822.54. This trade represents a 11.11% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Christina O'Connor sold 7,500 shares of IBEX stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $40.30, for a total transaction of $302,250.00. Following the completion of the sale, the insider owned 29,231 shares in the company, valued at approximately $1,178,009.30. This trade represents a 20.42% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 97,465 shares of company stock worth $3,882,291. Insiders own 3.40% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on IBEX shares. Wall Street Zen cut shares of IBEX from a "strong-buy" rating to a "buy" rating in a report on Saturday, September 12th. Weiss Ratings raised shares of IBEX from a "buy (b-)" rating to a "buy (b)" rating in a report on Monday, October 12th. Finally, Robert W. Baird boosted their price objective on shares of IBEX from $40.00 to $44.00 and gave the company a "neutral" rating in a report on Monday, September 28th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $42.00.
Check Out Our Latest Analysis on IBEX
IBEX Company Profile
(
Get Free Report)
IBEX Limited NASDAQ: IBEX is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services.
The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider IBEX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IBEX wasn't on the list.
While IBEX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.